B of A Securities Maintains Buy on RxSight, Lowers Price Target to $36

RxSIGHT, INC. +5.97%

RxSIGHT, INC.

RXST

0.00

B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ: RXST) with a Buy and lowers the price target from $60 to $36.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via